Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AMX | VZ |
|---|---|---|
| Price | $22.06 | $47.27 |
| Change today | ▼ 0.11% | ▲ 1.60% |
| Market cap | $65.96B | $196.38B |
| Return, 3 months | -14.1% | +5.2% |
| Return, year to date | +8.0% | +21.9% |
| Return, 1 year | +10.1% | +16.9% |
| P/E (TTM) | 13.0 | 12.3 |
| P/B | 2.6 | 1.9 |
| P/E percentile vs own 5y | 33rd | 80th |
| Dividend yield | 2.71% | 5.91% |
| Revenue growth (YoY, latest qtr) | +3.1% | -0.7% |
| Net profit growth (YoY) | +9.3% | -22.9% |
| Gross margin | 62.4% | 59.3% |
| Operating margin | 21.2% | 20.5% |
| Net margin | 9.4% | 11.6% |
| Return on equity | 20.3% | 15.6% |
| Analyst target vs. price | +43.6% | +5.9% |
| Analyst buy share | 67% | 36% |
| RSI (14) | 29 | 37 |
| 30-day volatility | 14.0% | 21.7% |
| Max drawdown, 1 year | -19.1% | -17.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.